Insider trading

Period: 12 months Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

46,028 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

46,028 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

46,028 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

46,028 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
46,028 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
46,028 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

46,028 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
1 Apr 2026
HOLLERAN KEVIN President and CEO
Sold on a plan
$703.15K 52,389 at 13.42
7.0%
Planned (10b5-1)
1 Apr 2026
Frates Caton Executive Vice President
Sold at will
$695.10K 700 at 993.00
10.7%
Not planned
1 Apr 2026
Moura Timothy See Remarks
Sold on a plan 2×
$663.47K 25,721 at 25.79
12.2%
Planned (10b5-1)
1 Apr 2026
Redmile Group, LLC 10% owner · indirect
Sold at will
$643.04K 169,265 at 3.80
1.1%
Not planned
1 Apr 2026
Fauber Robert President and CEO
Sold on a plan 3×
$642.21K 1,467 at 437.77
1.9%
Planned (10b5-1)
1 Apr 2026
Phillips Dominic SEE REMARKS
Sold on a plan
$640.67K 20,139 at 31.81
4.2%
Planned (10b5-1)
1 Apr 2026
Texier Thomas Group Head of Clearing
Sold on a plan 2×
$627.72K 14,427 at 43.51
5.6%
Planned (10b5-1)
1 Apr 2026
Redmile Group, LLC 10% owner
Sold at will
$617.40K 162,517 at 3.80
1.3%
Not planned
1 Apr 2026
Kidd Mark EVP, GM Data Centers & ALM
Sold on a plan
$616.26K 6,000 at 102.71
4.6%
Planned (10b5-1)
1 Apr 2026
Green Jason Elliot EVP and CCO
Sold at will
$612.99K 7,500 at 81.73
46.0%
Not planned
1 Apr 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 3×
$606.90K 3,000 at 202.30
2.0%
Planned (10b5-1)
1 Apr 2026
Raghunathan Vivek SVP, Engineering
Sold on a plan
$592.25K 3,876 at 152.80
1.4%
Planned (10b5-1)
1 Apr 2026
Willis Austin Chandler Chief Executive Officer
Sold on a plan 3×
$590.07K 3,400 at 173.55
1.8%
Planned (10b5-1)
1 Apr 2026
Van Den Born Simon President
Sold on a plan 2×
$577.10K 13,264 at 43.51
0.9%
Planned (10b5-1)
1 Apr 2026
Crystal Adam President, R&D
Sold on a plan
$572.48K 27,000 at 21.20
19.3%
Planned (10b5-1)
1 Apr 2026
Shaughnessy James P Chief Legal Officer
Sold on a plan 3×
$562.01K 12,000 at 46.83
18.3%
Planned (10b5-1)
1 Apr 2026
Sold on a plan 2×
$537.94K 11,000 at 48.90
70.3%
Sold half or more
1 Apr 2026
Dearborn Joel Alan JR COO, International
Sold on a plan 6×
$532.49K 3,500 at 152.14
11.7%
Planned (10b5-1)
1 Apr 2026
GRAY PETER L PRES LE Licensing, CAO & GC
Sold at will
$515.43K 11,454 at 45.00
7.6%
Not planned
1 Apr 2026
Piontek Gregg Senior Vice President and CFO
Sold on a plan
$507.86K 35,000 at 14.51
4.0%
Planned (10b5-1)
1 Apr 2026
Davies Philip D Corp. VP - Sales
Sold on a plan 8×
$501.88K 3,072 at 163.37
61.5%
Sold half or more
1 Apr 2026
Blum Robert I President & CEO
Sold on a plan
$499.73K 7,500 at 66.63
1.7%
Planned (10b5-1)
1 Apr 2026
Rubenstein Andrew H. CEO and President
Sold on a plan
$497.28K 45,000 at 11.05
1.1%
Planned (10b5-1)
1 Apr 2026
Neville Patrick Sean Director · indirect
Sold on a plan
$490.20K 5,000 at 98.04
100%
Sold half or more
1 Apr 2026
Dambkowski Carl Chief Medical Officer
Sold on a plan 3×
$466.62K 5,500 at 84.84
2.6%
Planned (10b5-1)
1 Apr 2026
FARRELL PETER C Director
Sold on a plan
$450.00K 2,000 at 225.00
3.2%
Planned (10b5-1)
1 Apr 2026
Bernstein Harold President, R&D & CMO
Sold on a plan 3×
$441.90K 15,000 at 29.46
100%
Sold half or more
1 Apr 2026
STETZ MATTIAS Chief Operating Officer
Sold on a plan
$441.44K 20,000 at 22.07
7.8%
Planned (10b5-1)
1 Apr 2026
Liu Joy EVP and Chief Legal Officer
Sold on a plan
$439.29K 978 at 449.17
4.3%
Planned (10b5-1)
1 Apr 2026
TYSON MITCHELL G Director
Sold at will
$423.10K 10,000 at 42.31
23.1%
Not planned
1 Apr 2026
Wang Hsueh-Chun SVP/COO IC & US/EU Mnstrm Ops
Sold at will 3×
$420.83K 10,000 at 42.08
6.1%
Not planned
1 Apr 2026
Sloan Sheldon Chief Medical Officer
Sold on a plan
$397.90K 7,958 at 50.00
100%
Sold half or more
1 Apr 2026
Ridloff Elena Director
Sold on a plan 2×
$392.92K 4,600 at 85.42
100%
Sold half or more
1 Apr 2026
Cochran Hope F Director
Sold on a plan
$390.45K 1,566 at 249.33
6.1%
Planned (10b5-1)
1 Apr 2026
Burrows Scott L Chief Financial Officer
Sold on a plan 2×
$370.08K 7,500 at 49.34
7.1%
Planned (10b5-1)
1 Apr 2026
Peterson Adam K 10% owner
Sold at will
$348.31K 61,000 at 5.71
2.3%
Not planned
1 Apr 2026
Lund Deanna H EVP & CFO
Sold on a plan 5×
$348.13K 5,000 at 69.63
1.6%
Planned (10b5-1)
1 Apr 2026
Toth Peter EVP, Chief Sustain & Dev Off
Sold on a plan
$339.27K 3,000 at 113.09
5.4%
Planned (10b5-1)
1 Apr 2026
Simpson Gary D. Co-Chief Executive Officer
Sold on a plan
$337.16K 27,234 at 12.38
4.5%
Planned (10b5-1)
1 Apr 2026
Clum Brent W. Co-CEO and CFO
Sold on a plan
$337.16K 27,234 at 12.38
3.3%
Planned (10b5-1)
1 Apr 2026
JOYCE CHRISTOPHER J Chief Legal and Admin. Officer
Sold on a plan
$320.49K 18,013 at 17.79
5.6%
Planned (10b5-1)
1 Apr 2026
Hopkinson Craig C. EVP R&D, Chief Medical Officer
Sold on a plan
$319.60K 9,000 at 35.51
9.5%
Planned (10b5-1)
1 Apr 2026
Palmer Stephen R Vice President of Accounting
Sold on a plan
$317.50K 1,000 at 317.50
2.9%
Planned (10b5-1)
1 Apr 2026
Dean Lia Pres, Banking & Prem. Products
Sold on a plan
$314.05K 1,692 at 185.61
2.5%
Planned (10b5-1)
1 Apr 2026
Sold at will
$313.97K 11,988 at 26.19
18.6%
Not planned
1 Apr 2026
REED ELIZABETH E Chief Legal Officer and GC
Sold on a plan
$300.00K 10,000 at 30.00
8.7%
Planned (10b5-1)
1 Apr 2026
Silverman Josh Director
Sold on a plan 2×
$298.02K 6,074 at 49.07
4.4%
Planned (10b5-1)
1 Apr 2026
Gibbon Virgilio Deloy Capobianco Chief Executive Officer
Sold at will
$292.11K 19,500 at 14.98
13.0%
Not planned
1 Apr 2026
Sold on a plan
$290.29K 11,810 at 24.58
5.1%
Planned (10b5-1)
1 Apr 2026
Miosi Salvatore A President & COO
Sold on a plan
$286.98K 10,931 at 26.25
1.8%
Planned (10b5-1)
Showing 24,701–24,750 of 46,028. ← Newer Page 495 of 921 Older →